{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 444583283
| IUPAC_name = 4-methoxy-2-(5-methoxy-3-methylpyrazol-1-yl)-6-methylpyrimidine
| image = Epirizole.png

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|epirizole}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = Rx-only
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 18694-40-1
| ATC_prefix = none
| ATC_suffix =  
| ATC_supplemental =  
| PubChem = 3242
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB08991
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 3B46O2FH8I
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01394
|  ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 3129
|  smiles = n1c(OC)cc(nc1n2nc(cc2OC)C)C
|  StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C11H14N4O2/c1-7-5-9(16-3)13-11(12-7)15-10(17-4)6-8(2)14-15/h5-6H,1-4H3
|  StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = RHAXSHUQNIEUEY-UHFFFAOYSA-N

<!--Chemical data-->
| chemical_formula =  
| C=11 | H=14 | N=4 | O=2 
| molecular_weight = 234.25 g/mol
}}

'''Epirizole''' ([[International Nonproprietary Name|INN]]) is a nonsteroidal anti-inflammatory drug.


{{Anti-inflammatory and antirheumatic products}}

[[Category:Nonsteroidal anti-inflammatory drugs]]


{{musculoskeletal-drug-stub}}